[Biological standardization].

in a screen should present with thrombophilia, and for the measurement of protein S in the therapeutic products, virus inactivated fresh frozen plasma and prothrombin complex concentrates. There are sufficient stocks to last two years based on the current unrestricted usage. The number of approved biotherapeutic monoclonal antibodies (mAb) and associated modalities, re-purposed and under development is increasing, and has most extraordinarily in the light of COVID-19 pandemic. A continued interest in these products is driven by improved understanding of disease targets and their clinical success, given their specificity, stability, long half-life, and relatively good safety profile.

• Publication year

  1972

• Venue

  Harefuah

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/jama.1951.02920310076037PMID 4656498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Body Temperature Drop as a Humane Endpoint in Snake Venom-Lethality Neutralization Tests

  2023influential citation
• Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research

  2023cites this paper
• Short birth interval and its predictors among reproductive age women in high fertility countries in sub-Saharan Africa: a multilevel analysis of recent Demographic and Health Surveys

  2023cites this paper
• Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations

  2022cites this paper
• Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease

  2022cites this paper
• Points to Consider in the Development and Information Provision of Vaccines for Vaccination during Pregnancy: A Survey

  2022influential citation
• Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting

  2022cites this paper
• Dynamics of biosimilar uptake in emerging markets

  2022cites this paper
• Current Opinion in LAIV: A Matter of Parent Virus Choice

  2022cites this paper
• Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells

  2022cites this paper
• Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars

  2022cites this paper
• Biosimilars: Harmonizing the Approval Guidelines

  2022cites this paper
• Incidence and predictors of left atrial appendage thrombus on transesophageal echocardiography before elective cardioversion

  2022cites this paper
• Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell Transplantation Program

  2022cites this paper
• Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants

  2021cites this paper
• Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

  2021cites this paper
• Calculation of the Median Lethal Dose and Low Lethal Dose Using the CombiStats Biometric Software

  2021cites this paper
• Analytical Performance Assessment of the Prothrombin Time and Activated Partial Thromboplastin Time Tests by Roche Cobas t511 Coagulation Analyzer

  2021cites this paper
• Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2

  2021cites this paper
• Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine

  2021influential citation
• Frontiers in Dentistry

  2021cites this paper
• IMMUNOGENICITY AND IMPACT ON NASOPHARYNGEAL CARRIAGE OF A SINGLE DOSE OF PCV10 GIVEN TO VIETNAMESE CHILDREN AT 18 MONTHS OF AGE

  2021cites this paper
• Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns

  2021cites this paper
• Quantifying SARS-CoV-2 viral load: current status and future prospects

  2021cites this paper
• Impact of Early COVID-19 Advice and Guidelines on the Blood Supply in Low- and Middle-Income Countries

  2021cites this paper
• Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders

  2021cites this paper
• Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review

  2021cites this paper
• Maintaining Plasmodium falciparum gametocyte infectivity during blood collection and transport for mosquito feeding assays in the field

  2021cites this paper
• Enhancing the blood safety program in Myanmar: Report on projects of global extension of medical technologies of Japan.

  2021cites this paper
• Potential Role of Personal Protective Equipment Use in the Protection Against COVID-19 Infection Among Health Care Workers

  2020cites this paper
• The controversy around technical standards for similar biotherapeutics: barriers to access and competition?†

  2020cites this paper
• Rabies Prevention in Asia: Institutionalizing Implementation Capacities

  2020influential citation
• Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture

  2020cites this paper
• Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: Harmonizing the manual tilt tube method

  2020cites this paper
• Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine

  2020cites this paper
• A Review: Wolbachia-Based Population Replacement for Mosquito Control Shares Common Points with Genetically Modified Control Approaches

  2020cites this paper
• A REVIEW ARTICLE ON BIOSIMILARS IN RHEUMATOLOGY

  2020cites this paper
• Regulatory challenges with biosimilars: an update from 20 countries

  2020cites this paper
• Traceable Impedance-Based Dispensing and Cloning of Living Single Cells

  2020cites this paper
• Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study

  2020cites this paper
• Plasmodium falciparum pre-erythrocytic stage vaccine development

  2020cites this paper
• Association of Personal Protective Equipment Use with Successful Protection Against COVID-19 Infection Among Health Care Workers

  2020cites this paper
• Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults

  2019cites this paper
• More than a Toxin: Protein Inventory of Clostridium tetani Toxoid Vaccines

  2019cites this paper
• Estimation of the Residual Risk of Transfusion-Transmissible Infectious Agents in Korea

  2019cites this paper
• Timing of Intradermal Rabies Pre-exposure Prophylaxis Injections: Immunological Effect on Vaccination Response.

  2019cites this paper
• The Trans-Pacific Partnership’s patent linkage: Unfriending or befriending the right to biologics?

  2019cites this paper
• Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines

  2019influential citation
• Small Scale Purification of Inactivated Enterovirus A 71 Produced from Vero Cell Cultures and Purity Determination

  2019cites this paper
• Availability and safety of blood transfusion in low‐ and middle‐income countries

  2019cites this paper
• Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals

  2019cites this paper
• Current Perspectives on High-Throughput Sequencing (HTS) for Adventitious Virus Detection: Upstream Sample Processing and Library Preparation

  2018cites this paper
• A trail of sulfa research: from insulin to oxytocin

  2018cites this paper
• Allergen Preparation and Standardization: An Updat

  2018cites this paper
• Suitability of alternative adenosine triphosphate potency assay for lot release of Tokyo bacilli Calmette- Guerin-172-1 Vaccines in Thailand

  2018cites this paper
• Evaluation of the manufacturer-dependent differences in specific immunoglobulin E results for indoor allergens.

  2018cites this paper
• Gut microbial diversity is associated with lower arterial stiffness in women

  2018cites this paper
• A Chemical Study of Oklahoma Plants

  2018cites this paper
• Evaluation of Immunobiological Properties of Bordetella pertussis Vaccine Strains

  2018influential citation
• ChAd63 CS and MVA CS, novel malaria vaccine candidates

  2018cites this paper
• Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial

  2018cites this paper
• Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio

  2018influential citation
• The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity

  2018cites this paper
• Alpha-type phospholipase A2 inhibitors from snake blood

  2017cites this paper
• Immunoagglutination Test Using Monoclonal Antibodies Coupled to Latex Particles to Identify The Streptococcus Pneumoniae Capsular Polysaccharides Serotype 1, 5, 6B, 14 And 19F In Quimi-Vio Vaccine

  2017cites this paper
• Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model

  2017cites this paper
• A recombinant live attenuated tetravalent vaccine for the prevention of dengue

  2017cites this paper
• Dot Blot para determinar la identidad antigénica en vacunas conjugadas contra Streptococcus pneumoniae serotipo 19F

  2017influential citation
• Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis.

  2016cites this paper
• Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

  2016cites this paper
• Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools

  2016cites this paper
• Plasma is a strategic resource

  2016cites this paper
• Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

  2016cites this paper
• Questions regarding the safety and duration of immunity following live yellow fever vaccination

  2016cites this paper
• Biosimilars advancements: Moving on to the future

  2015cites this paper
• Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model

  2015cites this paper
• Randomized, double‐blind comparison of standard‐dose vs. high‐dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients

  2015cites this paper
• Current status and future prospects of yellow fever vaccines

  2015influential citation
• Processionary Moths and Climate Change : An Update

  2015cites this paper
• Relationship of immunogenicity to protective potency in acellular pertussis vaccines

  2014cites this paper
• Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers

  2014cites this paper
• for Human Cytomegalovirus Cell Culture Tests In Vitro Performance Relative to qPCR and Preliminary Evaluation of Next-Generation Sequencing

  2014influential citation
• Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer

  2014cites this paper
• Preliminary Evaluation of Next-Generation Sequencing Performance Relative to qPCR and In Vitro Cell Culture Tests for Human Cytomegalovirus

  2014influential citation
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective

  2014cites this paper
• Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

  2014cites this paper
• Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

  2013cites this paper
• Coagulation in children with liver disease

  2013cites this paper
• Cognitive function in patients with Type 2 Diabetes Mellitus: Relationship to stress hormone(Cortisol)

  2013cites this paper
• Environmental assessment and exposure reduction of cockroaches: a practice parameter.

  2013cites this paper
• Design, Synthesis and Structure–Activity Relationship of New Arginine Vasopressin Analogues Containing Proline Derivatives in Position 2

  2013cites this paper
• Nonclinical Development of BCG Replacement Vaccine Candidates

  2013cites this paper
• Impact of biosimilars in psoriasis treatment.

  2013cites this paper
• Environmental assessment and exposure control: a practice parameter--furry animals.

  2012cites this paper
• Coagulation assays and anticoagulant monitoring.

  2012cites this paper
• Manufacturing of Biodrugs

  2012cites this paper
• Anaesthetic activity of Phallusia nigra Savigny

  2012cites this paper
• Chapter 8 Bibliography

  2012cites this paper
• Bridging the gap

  2011cites this paper
• Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

  2011influential citation